- Home
- SLS vs EDF Comparison
SLS vs EDF Comparison
Compare SLS & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- EDF
- Stock Information
- Founded
- SLS 2012
- EDF 2010
- Country
- SLS United States
- EDF United States
- Employees
- SLS N/A
- EDF N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- EDF Investment Managers
- Sector
- SLS Health Care
- EDF Finance
- Exchange
- SLS Nasdaq
- EDF Nasdaq
- Market Cap
- SLS 169.6M
- EDF 148.8M
- IPO Year
- SLS N/A
- EDF N/A
- Fundamental
- Price
- SLS $1.54
- EDF $4.97
- Analyst Decision
- SLS
- EDF
- Analyst Count
- SLS 0
- EDF 0
- Target Price
- SLS N/A
- EDF N/A
- AVG Volume (30 Days)
- SLS 2.6M
- EDF 160.6K
- Earning Date
- SLS 08-12-2025
- EDF 01-01-0001
- Dividend Yield
- SLS N/A
- EDF 13.14%
- EPS Growth
- SLS N/A
- EDF N/A
- EPS
- SLS N/A
- EDF N/A
- Revenue
- SLS N/A
- EDF N/A
- Revenue This Year
- SLS N/A
- EDF N/A
- Revenue Next Year
- SLS N/A
- EDF N/A
- P/E Ratio
- SLS N/A
- EDF N/A
- Revenue Growth
- SLS N/A
- EDF N/A
- 52 Week Low
- SLS $0.77
- EDF $3.51
- 52 Week High
- SLS $2.12
- EDF $5.50
- Technical
- Relative Strength Index (RSI)
- SLS 45.96
- EDF 50.98
- Support Level
- SLS $1.47
- EDF $4.96
- Resistance Level
- SLS $1.73
- EDF $5.05
- Average True Range (ATR)
- SLS 0.11
- EDF 0.07
- MACD
- SLS -0.02
- EDF -0.01
- Stochastic Oscillator
- SLS 19.44
- EDF 33.00
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.